Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q3 2025 · 10-Q
Revenue$290.32M$290.32M+2.7% vs Q3 2024 Net Income$61.03M$61.03M+15.1% vs Q3 2024 EPS Diluted$1.22$1.22+15.1% vs Q3 2024 Gross Profit$161,049,000+2.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$65,091,000−8.9% Free Cash Flowderived$63,525,000−8.6% Margins · derivedGross margin55.5%−0.4 pt vs Q3 2024
Operating margin31.7%+1.0 pt vs Q3 2024
Net margin21.0%+2.3 pt vs Q3 2024
ended Dec 31, 2024 · filed Feb 6, 2025 · 37 d after period end